business

Lilly expects orforglipron obesity results in third quarter

Author2 months ago01 mins

Lilly expects orforglipron obesity results in third quarter

Source link

Leave a Reply Cancel reply

Related News

Adeia earnings missed by $0.01, revenue fell short of estimates

Author2 days ago 0

Earnings call transcript: Supernus Q2 2025 revenue beats forecast, EPS misses

Author2 days ago 0

Client Challenge

Author2 days ago 0

Client Challenge

Author2 days ago 0